| Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor beta 1 Fibrogenic Axis | |
| Liu, Xiao; Shan, Xiaoli; Chen, Huihua; Li, Zan; Zhao, Pei; Zhang, Chen; Guo, Wei; Xu, Ming; Lu, Rong | |
| 刊名 | FRONTIERS IN PHARMACOLOGY
 |
| 2019 | |
| 卷号 | 10 |
| 关键词 | cardiac fibrosis cardiac fibroblasts myofibroblasts angiotensin II transformation growth factor-beta 1 Smads |
| ISSN号 | 1663-9812 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3629350 |
| 专题 | 上海中医药大学 |
| 推荐引用方式 GB/T 7714 | Liu, Xiao,Shan, Xiaoli,Chen, Huihua,et al. Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor beta 1 Fibrogenic Axis[J]. FRONTIERS IN PHARMACOLOGY,2019,10. |
| APA | Liu, Xiao.,Shan, Xiaoli.,Chen, Huihua.,Li, Zan.,Zhao, Pei.,...&Lu, Rong.(2019).Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor beta 1 Fibrogenic Axis.FRONTIERS IN PHARMACOLOGY,10. |
| MLA | Liu, Xiao,et al."Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor beta 1 Fibrogenic Axis".FRONTIERS IN PHARMACOLOGY 10(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论